---
title: "Study: Pulse oximeters at one hospital shifted from overestimating to underestimating oxygen satur"
id: "stat-news-0-in-this-hospital-pulse-oximeters-went-from-overestimating-to-underestimating"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-in-this-hospital-pulse-oximeters-went-from-overestimating-to-underestimating"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/10/06/pulse-oximeters-overestimate-and-underestimate-blood-oxygen-study/?utm_campaign=rss"
published_at: "2026-10-06T08:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Study: Pulse oximeters at one hospital shifted from overestimating to underestimating oxygen satur
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-in-this-hospital-pulse-oximeters-went-from-overestimating-to-underestimating
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/10/06/pulse-oximeters-overestimate-and-underestimate-blood-oxygen-study/?utm_campaign=rss)
- **Published At:** 2026-10-06T08:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- A retrospective five-year review at Johns Hopkins found that the same model of **pulse oximeter** shifted from overestimating arterial oxygen saturation to underestimating it at higher oxygen levels. - The change in direction of bias affected all patients but was more pronounced in patients of color, compounding known concerns about racial disparities in oximeter accuracy. - The Hopkins authors compared pulse oximeter readings to arterial blood gas (ABG) measurements, the clinical gold standard for oxygen saturation. - Investigators and coauthors, including intensivists and pulmonologists, said the devices behave like a “black box” and could not explain why readings changed year to year. - The manufacturer of the devices used in the study, Masimo, said it was unaware of sensor, software, or manufacturing changes during the study period and noted multiple non-device factors (sensor type and placement, signal quality, perfusion) can affect readings. - The Hopkins paper was partly motivated by the FDA-funded EquiOx study, which itself found unexpected underestimation of oxygen levels rather than the anticipated overestimation in darker-skinned patients. - Retrospective and prospective studies to date (including a 2020 NEJM paper and prospective Emory work) have produced inconsistent findings: some show racial bias, others show underestimation, and prospective work suggests causes are multifactorial beyond skin pigmentation. - Clinical implications are substantial: overestimation risks undertreatment, while underestimation risks unnecessary interventions or prolonged hospitalization. - Authors and experts quoted in the reporting emphasized that inconsistent, changing bias makes it difficult for clinicians to adjust practice reliably, likening the problem to a clock that may be slow or fast unpredictably. - The study’s data did not establish a cause for the observed shift from overestimation to underestimation; the source article reports investigators and the manufacturer could not identify a definitive explanation.
## Clinical Analysis & Structured Key Points
New study finds pulse oximeters don't accurately track blood oxygen| STAT Skip to Main Content Health In this hospital, pulse oximeters went from overestimating to underestimating blood oxygen. Why? New study highlights inconsistencies in pulse oximeter readings over five years Manage alerts for this article Save this story for later Share this article PATRICK T. FALLON/AFP via Getty Images By Anil Oza Oct. 6, 2026 General Assignment Reporter Anil Oza [email protected] Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Pulse oximeters gained prominence during the Covid-19 pandemic, offering anyone a handheld tool to take stock of their blood oxygen level. But their newfound popularity also brought new attention to their limitations — several studies have shown that pulse oximeters overestimate blood oxygen levels when used on darker skin tones. This can make patients of color appear more healthy than they really are, resulting in worse health outcomes and exacerbated inequality. Advertisement Related Story No one’s quite sure how to fix pulse oximeters. The FDA asked this lab to find answers In the years since, researchers have tried to unpack what exactly is going wrong with these commonly used tools. A recent study , published in the Annals of the American Thoracic Society, adds to a growing body of evidence showing the issues with pulse oximeters are more than skin deep. In a retrospective study reviewing five years of data, researchers found that pulse oximeters at Johns Hopkins Hospital inexplicably went from overestimating blood oxygen levels to underestimating them in all patients at higher oxygen levels, though the inaccuracies were worse in patients of color. “One of the biggest problems with pulse oximeters is that they are this black box. I have no idea why we found what we found in this paper, and why it’s changing year over year,” said Ashraf Fawzy, a pulmonologist and critical care physician at Hopkins who is an author on the paper. In response, a spokesperson for Masimo, which manufactures the pulse oximeters used in the study, said it is “unaware of any sensor, software, or manufacturing changes during the study period evaluated in the publications that would explain the reported results.” They added that there are multiple factors that can affect a reading, including what type of sensor is used, where it is placed, signal quality, and perfusion. Advertisement “The study’s available data do not establish the cause of the reported shift from overestimation to underestimation,” they said. In addition, they pointed to two studies supported by the company that have not found differences in pulse oximeter efficacy based on skin tone. Pulse oximeters work by shining a light through the skin at two wavelengths, one of which is absorbed by oxygenated blood and the other by deoxygenated blood. The device then compares how much of each is absorbed, and calculates what percent of the blood is oxygenated. Using data from intensive care units across Hopkins, Fawzy’s study found that the same make of oximeter was not consistent in its readings throughout the years. The paper was trying to answer a question posed by a Food and Drug Administration-funded study of pulse oximeters, which was published earlier this year . That paper, called EquiOx, was intended to help researchers understand why pulse oximeters overestimated blood oxygen levels in patients with darker skin tones. Instead, it found that the devices were underestimating blood oxygen levels, a result the authors and outside commentators struggled to justify. It was one of the first studies to proactively take pulse oximeter readings from patients and compare them to an arterial blood gas test, which is the gold standard for blood oxygen levels, but much more invasive. Related Story FDA-funded study of pulse oximeter accuracy yields surprising and confusing results Taken together, these findings make it difficult for clinicians to know how to interpret pulse oximeter results. If they only overestimated or underestimated oxygen levels in patients with darker skin tones, physicians could adjust accordingly. But if pulse oximeters are inconsistent, it makes it more difficult to work around. Thomas Valley, a health services researcher and pulmonologist at University of Colorado Anschutz who was involved in a seminal 2020 New England Journal of Medicine paper bringing attention to pulse oximeters’ racial bias, compared pulse oximeters to a broken clock. “If you have a broken clock and you know how it’s going to be five minutes slow every time, you can adjust your routines to take care of that,” he said. But now, it’s unclear whether that metaphorical clock is running fast or slow. “That’s a huge problem, given how important these devices are,” he added. Advertisement In the Hopkins study, pulse oximeters gradually shifted from overestimates to underestimates over the course of the five years when compared to arterial blood gas tests. When oximeters overestimate oxygen levels, clinicians run the risk of not providing care to patients when they need it. But underestimating can also come with issues, like providing unnecessary care or keeping patients in the hospital longer than necessary. Overall, “it is not at all clear these things are fit for use in the way that we’re using them,” said Jack Iwashyna, a pulmonologist and critical care physician who is an author on the Hopkins paper. The recent crop of papers also raises a question about how to best study the shortcomings of pulse oximeters. The landmark 2020 paper that brought renewed attention to the devices’ bias was a retrospective, gleaning a trend from past data. Researchers at the time hoped prospective studies , where scientists actively collect data to get to the root of a problem, would be more helpful in understanding why pulse oximeters fell short in the way they do. But thus far, such studies have mostly raised more questions than answers. Another prospective study , from Emory University, found evidence of racial bias, but that the inaccurate results were not fully accounted for by variations in skin tone. Readings are likely impacted by factors other than molecules that impact skin pigmentation, such as conditions like anemia, cardiovascular disease, or liver disease, which are more common in patients of color, said Sivasubramanium Bhavani, an ICU physician at Emory who led that study. “It is more complicated than just skin tone,” he said. “We don’t know all the different causalities and how these things work. But, we do know that if you had the next generation of pulse oximeters, and you can claim that it was 100% calibrated for skin tone, all these other pathways are still going to affect it, and you may still have the same racial bias.” Covid-19 , public health , research Submit a correction request Reprints Anil Oza General Assignment Reporter Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Newsletter Understand how science, health policy, and medicine shape the world every day Please enter a valid email address. Sign Up Your data will be processed in accordance with our Privacy Policy and Terms of Service . You may opt out of receiving STAT communications at any time. Recommended First Opinion First Opinion October 6, 2026 I’m a doctor. Here’s what I want the public to know about AI tools and health care costs First Opinion First Opinion October 6, 2026 Why the FDA should not approve an ineffective multicancer screening test Advertisement Selling Longevity Selling Longevity October 6, 2026 STAT Plus: Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals Business Business October 5, 2026 STAT Plus: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit In the Lab In the Lab October 5, 2026 STAT Plus: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s Subscriber Picks
## Related Clinical Research

- [DOJ Expands Health Care Fraud Investigations with New Policies](https://medichelpline.com/clinical-feed/stat-news-0-the-trump-administration-is-doubling-down-on-health-care-fraud-investigations.md)
- [Preparing Marathons for Extreme Heat in a Changing Climate: Lessons from NYC](https://medichelpline.com/clinical-feed/stat-news-2-opinion-i-treated-heat-stroke-at-the-nyc-marathon-marathons-need-to-prepare-for.md)
- [Olive oil before carbs and blood sugar: what the mouse study found](https://medichelpline.com/clinical-feed/medical-news-today-0-olive-oil-shot-trend-what-science-really-says-about-fat-and-glucose-response.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.